Effect of Rivaroxaban on Fibrinolytic Therapy in Massive Pulmonary Embolism: Two Cases

The risk of dying from a pulmonary embolism (PE) is estimated to be about 30% if inotropic support is required and no cardiopulmonary arrest occurs. Fibrinolysis in massive PE is regarded as a life-saving intervention, unless there is a high risk of bleeding following the use of the fibrinolytic the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hye-Jin, Koo, So-My, Ham, Nam-Suk, Kim, Ki-Up, Uh, Soo-taek, Kim, Yang-Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982239/
https://www.ncbi.nlm.nih.gov/pubmed/24734100
http://dx.doi.org/10.4046/trd.2014.76.3.127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982239/
https://www.ncbi.nlm.nih.gov/pubmed/24734100
http://dx.doi.org/10.4046/trd.2014.76.3.127

Ejemplares similares